by | Jun 28, 2024 | Publications
Front Biosci (Landmark Ed). 2024 Jun 17;29(6):216. doi: 10.31083/j.fbl2906216. ABSTRACT The treatment options for multiple myeloma (MM) have undergone significant transformation with the advent of immunotherapy. Novel therapies that focus on tumor antigens now drive...
by | Jun 28, 2024 | Publications
Skeletal Radiol. 2024 Jun 27. doi: 10.1007/s00256-024-04733-0. Online ahead of print. ABSTRACT OBJECTIVE: To develop a whole-body low-dose CT (WBLDCT) deep learning model and determine its accuracy in predicting the presence of cytogenetic abnormalities in multiple...
by | Jun 28, 2024 | Publications
Support Care Cancer. 2024 Jun 27;32(7):468. doi: 10.1007/s00520-024-08665-2. ABSTRACT PURPOSE: While numerous studies underscore the benefits of early palliative care (EPC) for patients with solid tumors, its effects on patients with multiple myeloma (MM) are not as...
by | Jun 28, 2024 | Publications
Clin Exp Med. 2024 Jun 27;24(1):137. doi: 10.1007/s10238-024-01411-2. ABSTRACT Patients with multiple myeloma (MM) have an increased risk of sepsis due to underlying disease- and treatment-related immunosuppression. However, data on sepsis incidence, causative...
by | Jun 28, 2024 | Publications
Nat Rev Dis Primers. 2024 Jun 27;10(1):46. doi: 10.1038/s41572-024-00535-9. NO ABSTRACT PMID:38937486 | DOI:10.1038/s41572-024-00535-9
by | Jun 28, 2024 | Publications
Nat Rev Dis Primers. 2024 Jun 27;10(1):45. doi: 10.1038/s41572-024-00529-7. ABSTRACT Multiple myeloma (MM) is a haematological lymphoid malignancy involving tumoural plasma cells and is usually characterized by the presence of a monoclonal immunoglobulin protein. MM...
